Drugmaker drops cheaper version of drug, leaving patients stuck with pricier one

Kids who need hormone-blocking drugs to prevent premature puberty — or delay it if they're trans — have lost a more affordable option. The remaining nearly identical drug costs eight times more.

Related Keywords

Sudeep Taksali ,Kristina Barker ,Zoumas Lubeski ,Erin Fox ,Erica Eugster ,Blaise Coleman ,Jeremy Kahn ,Endo Pharmaceuticals ,University Of Utah Health ,Indiana University School Of Medicine ,Corporate Affairs Heather Zoumas Lubeski ,Drug Administration ,Vice President ,Lupron Depot Ped ,Utah Health ,Preventing Drug Shortages Act ,Indiana University School ,Pediatric Endocrinology ,